March 30, 2017

Drug is used as prophylaxis of migraine headache in adults and adolescents 12 years of age and older. 

March 29, 2017

Genentech’s Ocrevus (ocrelizumab) is used to treat adult patients with relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.

March 29, 2017

QuickFire Challenge winners will receive grants totaling up to $200,000, entrance to a Johnson & Johnson Innovation – JLABS facility and/or mentoring from Johnson & Johnson Innovation.

March 28, 2017

Regeneron’s Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable.

March 27, 2017

Tesaro’s Zejula is an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response (CR or PR) to platinum-based chemotherapy.

March 24, 2017

Drug is intended for the treatment of pemphigus vulgaris, a painful, disfiguring and potentially fatal autoimmune disease characterized by progressive blistering of skin and/or mucous membranes.

March 23, 2017

Merck KGaA and Pfizer's AMD Serono unit's Bavencio (avelumab) is intended for the treatment of adults and pediatric patients 12 years and older with MCC, including those who have not received prior chemotherapy.


March 21, 2017

Newron Pharmaceuticals’ Xadago was approved as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes.

March 20, 2017

Entresto lowered HbA1c levels — a measure of average blood glucose levels for the past two to three months — after one year of treatment for heart failure, according to Novartis-funded research.

March 17, 2017

A little more than a year after its approval, Adapt Pharma made the case for the effectiveness of its Narcan (naoloxone) Nasal Spray 4 mg at the annual American Academy of Pain Medicine in Orlando.

March 17, 2017
Based on new data about Amgen’s PCSK9 inhibitor cholesterol drug Repatha, CVS Health’s chief medical officer, Dr. Troyen Brennan, told Reuters that the number of patients eligible to use the drug could quadruple. He noted that the data — published in the New England Journal of Medicine and showing Repatha’s ability to reduce heart attack, stroke, heart disease deaths, chest pain hospitalizations and stent and bypass procedures by 15% — would need to be reviewed by heart experts. (Reuters)
March 14, 2017

The Congressional Budget Office on Monday released its assessment of the American Health Care Act, the House GOP's proposal to replace Obamacare, and The Hill is outlining five of the biggest takeaways. Among them are the 24 million individuals who would be uninsured by 2026, with 14 million losing coverage next year, as well as the expected reduction in the federal deficit that the bill would bring about. The bill would also create extensive changes to Medicaid.  (The Hill)

March 9, 2017

CVS Pharmacy added Arizona, Georgia, Iowa and South Carolina to the list, and now 41 states are able to increase access to the medication. 

March 9, 2017

For the sixth consecutive year, Google earned the top spot, based upon employee reviews.

March 9, 2017
Some 83% of patients with chronic myelogenous leukemia taking Gleevec (imatinib) can live 10 years or longer, according to new data published in the New England Journal of Medicine, NBC News is reporting. The study looked at the original 1,100 patients in the Gleevec trial, though in the years since approval several generics have hit the market. The data shows the drug, which targets a CML-specific genetic mutation, has a 10-year survival rate of nearly 83%. (NBC News)
March 6, 2017

DSN examines chain pharmacy, including in-depth coverage of the specialty market, in this multi-page report.

March 3, 2017

Nasal spray is for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria.

March 3, 2017

The bill will create more accountability for how federal health programs deliver prescription drug services, NCPA noted.

March 2, 2017

Odactra, manufactured for Merck, Sharp & Dohme, a subsidiary of Merck, by Catalent Pharma, provides patients an alternative treatment to allergy shots to help address their symptoms.

March 1, 2017

The tablets, in combination with somatostatin analog therapy, are used for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled.

February 28, 2017

The solutions are indicated for the symptomatic relief of cough in adults and children 6 years of age and older.

February 24, 2017

Pharmacists at Albertsons banner stores in 13 states can dispense Adapt Pharma’s Narcan Nasal Spray and counsel patients on how to use the opioid overdose reversal drug. 

February 24, 2017

Panelists offered perspectives on efforts currently underway to move the healthcare system toward one that rewards innovation, delivers better quality and puts the patient at the center of the value equation.

February 16, 2017

Administered as an injection, it is intended for patients who are candidates for systemic therapy or phototherapy and have failed to respond, or have stopped responding to other systemic therapies.